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Rapid leukocyte migration by integrin-
independent flowing and squeezing
Tim Lämmermann1, Bernhard L. Bader3, Susan J. Monkley4, TimWorbs5, Roland Wedlich-Söldner2, Karin Hirsch1,
Markus Keller3, Reinhold Förster5, David R. Critchley4, Reinhard Fässler1 & Michael Sixt1
All metazoan cells carry transmembrane receptors of the integrin family, which couple the contractile force of the
actomyosin cytoskeleton to the extracellular environment. In agreement with this principle, rapidlymigrating leukocytes use
integrin-mediated adhesion when moving over two-dimensional surfaces. As migration on two-dimensional substrates
naturally overemphasizes the role of adhesion, the contribution of integrins during three-dimensional movement of
leukocytes within tissues has remained controversial.We studied the interplay between adhesive, contractile and protrusive
forces during interstitial leukocyte chemotaxis in vivo and in vitro. We ablated all integrin heterodimers from murine
leukocytes, and show here that functional integrins do not contribute to migration in three-dimensional environments.
Instead, these cells migrate by the sole force of actin-network expansion, which promotes protrusive flowing of the leading
edge. Myosin II-dependent contraction is only required on passage through narrow gaps, where a squeezing contraction of
the trailing edge propels the rigid nucleus.
The current model ofmetazoan cell migration is frequently described
as a multistep cycle: F-actin polymerization at the cell front pushes
out a membrane protrusion that subsequently becomes anchored to
an extracellular substrate by transmembrane receptors of the integrin
family. Integrins are dynamically coupled to the cytoskeleton and
transduce the internal force that is generated when myosin II con-
tracts the actin network. Contraction imposes retrograde pulling
forces on the integrins, which in turn facilitates forward locomotion
of the cell body1–3. The mammalian integrin family consists of 24
different functional heterodimers with individual binding specifici-
ties for cellular and extracellular ligands4. The integrin repertoire of
each cell type defines which substrate it can use for this ‘haptokinetic’
(adhesion driven)mode ofmigration. Such intimate linkage between
substrate-specific adhesion and migration restricts the migrating
cells to preformed pathways, and thereby creates the determinism
that is essential formany of the precise cell trafficking and positioning
processes underlying compartmentalization and patterning during
development and regeneration. As all mammalian cells with the
exception of erythrocytes carry integrins on their surface, it is rea-
sonable to assume that haptokinesis is a universal phenomenon4,5.
Leukocytes are outstanding cells, as they are scattered throughout
the body and have the potential to infiltrate any type of tissue. Rather
than following exact routes and being restricted to specific compart-
ments, leukocytes frequently undergo stochastic swarming with single
cell migration velocities that are up to 100 times faster than mesench-
ymal and epithelial cell types6,7. What makes leukocytes so quick and
flexible? In contrast to slow cells, migrating leukocytes undergo fre-
quent shape changes and were therefore morphologically described as
‘‘amoeboid’’8. How these shape changes relate to actual locomotion is
poorly investigated, and it is currently unknown if amoeboid migra-
tion represents a specialized strategy or just an accelerated variant of
the above introduced migration paradigm that is only well established
for slow cells. We therefore studied the inter-dependency of adhesion,
protrusion and contraction in inflammatory cells. We demonstrate
that integrin-mediated adhesion is only necessary to overcome tissue
barriers like the endothelial layer, while interstitial migration is auto-
nomous from the molecular composition of the extracellular environ-
ment. Such adhesion-independent migration is driven by protrusive
flowing of the anterior actin network of the cell and supported by
squeezing actomyosin contractions of the trailing edge to propel the
rigid nucleus through narrow spaces.
Dendritic cells migrate without integrins
As a model system to study interstitial leukocyte migration in vivo, we
focused on dendritic cells (DCs), phagocytes that reside within peri-
pheral tissues such as skin. They become activated upon wounding or
infection, sample antigens and quickly migrate via the afferent lymph-
atic vessels into the draining lymph node where they act as antigen
presenting cells9. DCmigration is primarily guided by the two chemo-
kines CCL19 and CCL21; these are expressed in lymphatic endothe-
lium and the lymph nodes’ T-cell area, and bind the CC-chemokine
receptor 7 (CCR7), which is upregulated on DCs upon activation10.
Flow cytometric analysis of DCs generated from mouse bone-
marrow-derived stem cells revealed expression of the b1, b2, b7 and
av integrin families (Fig. 1a). To investigate the role integrins play in
DC migration in vivo, we used a combinatorial mouse genetics
approach to delete all integrin heterodimers from the surface of
DCs, thereby generating phenotypically normal pan-integrin-
deficient (integrin2/2) DCs (Fig. 1a, see Supplementary Material,
Methods, and Supplementary Figs 1, 2, 4c). We co-injected 1:1 mix-
tures of differentially labelled integrin2/2 and wild-type DCs into the
dermis of mouse footpads and quantified their arrival in T-cell areas
of the draining lymph nodes. Surprisingly, wild-type and integrin2/2
DCs arrived and localized in the T-cell area in an indistinguishable
manner (Fig. 1b, c, Supplementary Fig. 3), whereas CCR72/2 DCs,
which cannot interpret the directional information, failed to enter
the lymph node (Fig. 1c) as previously described10. We next targeted
integrin functionality indirectly by deleting the talin1 gene in DCs
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(Supplementary Fig. 4a). The interaction of talin1 with integrin
cytoplasmic domains is required for integrin activation, ligand bind-
ing and coupling of F-actin to adhesion sites11. Accordingly, talin1
gene ablation in DCs did not affect the levels of integrin expression,
but completely abolished their ability to bind ligands (Supple-
mentary Fig. 4b–d). Again, arrival of talin12/2 DCs in lymph nodes
did not significantly differ from wild-type DCs (Fig. 1c).
To allow for a detailed comparison of the cellular dynamics of
wild-type and integrin2/2 DCs within the different physiological
environments of their migration route, we employed two in situ
imaging approaches (Fig. 2). Representing the starting point of DC
migration, the interstitial space of the dermis is dominated by fibrillar
arrays of collagen bundles12. Using a newly developed set-up of ex vivo
live cell imaging within explanted ear dermis, we could directly visu-
alize DCsmoving towards and entering the afferent lymphatic vessels
by wide-field microscopy (Fig. 2b, c, Supplementary Fig. 5). Single
cell tracking revealed no difference in the migratory behaviour of
wild-type, integrin2/2 and talin12/2 DCs (Fig. 2c, d).
The lymphnode constitutes a fundamentally different environment
for cellular migration, as it contains almost no freely accessible extra-
cellular matrixmolecules but is densely packed with lymphocytes and
stroma cells13,14. To analyse the dynamics of intranodal DCmigration
from the subcapsular sinus towards the T-cell area, we employed a
set-up of intravital two-photon microscopy of the popliteal lymph
nodes15. Evaluating a range of motility parameters, including cell
velocity, directional persistence, mean square displacement, motility
coefficients andmorphology, we found that themovement behaviour
of wild-type and integrin2/2 DCs was indistinguishable (Fig. 2e, f,
Supplementary Videos 1–3, data not shown).
2D but not 3D migration is integrin-dependent
On their way into the lymph node, DCs do not cross significant tissue
barriers, such as continuous endothelial or epithelial linings12. As
these processes have been shown to be integrin-dependent16, we also
tested for extravasation of integrin2/2 leukocytes from the blood
stream into the inflamed dermis, and found that it was indeed abo-
lished (Fig. 2g, Supplementary Fig. 6). This finding corroborates the
extravasation model in which integrin-mediated tight immobiliza-
tion of leukocytes to the luminal endothelial surface is necessary to
counteract the shear forces imposed by the blood flow16. In line with
this in vivo finding, we found that integrin2/2 DCs were entirely
unable to adhere to andmigrate on two-dimensional (2D) substrates.
Gravity was obviously not sufficient to confine the non-adherent cells
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Figure 1 | Migration of integrin-deficient dendritic cells into lymph nodes.
a, Flow cytometric analysis of integrin subunits of wild-type (WT) and
integrin-deficient (Itg2/2) dendritic cells (DCs) (integrin, unshaded; isotype
control, grey-shaded). b, c, In vivo migration of DCs after subcutaneous
injection into hind footpads of WT mice. At the time points indicated,
arrival of differentially labelled DCs in the lymph node was analysed.
b, Localization of DCs after 48 h. Composite of six separate images of a single
lymph node. Scale bar, 200mm; B, B-cell follicle; T, T-cell cortex.
c, Quantitative histology. Dotted line at 0.5, 50% of DCs that migrated into
the lymph node are knockout DCs; Tln1, talin1. Red dots indicate single
experiments (1 lymph node); box shows median, 25%, 75% percentile;
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Figure 2 | Integrin-independent
interstitial leukocyte migration
in vivo. a, Scheme of the dendritic
cell (DC) migration path from the
skin via lymphatic vessels to the
lymph node; B, B-cell follicle; BV,
bloodvessel;D, dermis; E, epidermis;
LN, lymph node; LV, lymphatic
vessel; T, T-cell cortex.
b–d, Migration of DCs within the
dermis of ear explants. b, Tracks of
DCs (red) entering LYVE-11 LVs
(green). c, Confocal images of whole
mount ear explants 2 h after addition
of DCs (red). DCs locate within the
lumen of LVs; all scale bars, 50mm.
d, Speed and directional persistence
(DP,mean6 s.d.) of single cells (dots)
for wild-type (WT), integrin2/2
(Itg2/2) and talin12/2 (Tln12/2)
DCs. Red line, mean. e, f, Intravital
two-photon microscopy. e, 3D
tracking ofWT (green, blue line) and
Itg2/2 (red, yellow line) DCs
migrating in the interfollicular areas.
f, Quantificationof the average speed
and DP (mean6 s.d.) of tracked
single cells (dots). Red line, mean.
g, Quantification of granulocytes
that extravasated fromblood into ear
dermis (n5 6 for each mouse line).
Red line,median.*P,0.05 (posthoc).
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(Fig. 3a, b, Supplementary Fig. 4d, Supplementary Video 4). We
conclude that extravasation requires integrin-mediated adhesion.
To better mimic the interstitial microenvironment, we established
chemotaxis assays within artificial three-dimensional (3D) matrices
of fibrin (a ligand for b2 and b3 integrins) and collagen I (a ligand for
several members of the b1 integrin subfamily). In this system, DCs
persistently migrated along soluble gradients of CCL19 and showed
amoeboid morphology and velocities that were comparable to our
(and previously published17) in vivo observations. In agreement with
our in vivo data and in contrast to 2D migration, integrin2/2 and
talin12/2 DCs migrated with speed and directional persistence that
were indistinguishable from wild-type cells (Fig. 3c, Supplementary
Fig. 7a, Supplementary Video 5). We also observed integrin-
independent migration for chemotaxing B cells and granulocytes,
suggesting a broader prevalence of this functional principle (Fig. 3d,
Supplementary Fig. 7b).
Functional dissociation of front and back
To mechanistically understand how cells can move in the absence of
integrin-mediated traction forces, we compared the integrin-
dependent movement pattern of fibroblasts with that of leukocytes
and found a striking difference. Leading edge protrusions of
fibroblasts translocated collagen fibres towards the cell body, indi-
cating the presence of rearward pulling forces and demonstrating
that protrusion, adhesion and contraction are tightly coupled in this
cell type (Supplementary Video 6)18,19. In contrast, chemotaxing DCs
protruded without signs of anterior pulling forces while the trailing
edge displayed an irregularly alternating contractile pattern. Con-
traction was characterized by shrinkage of the cell rear with con-
comitant forward-streaming of cytoplasmic matter (Supplementary
Video 7). When we dynamically visualized activated myosin II, the
motor system mediating contraction1,2,20, by time-lapse imaging of
DCs expressing a myosin light chain–GFP fusion protein, we found
accumulation at the cell rear during contractile phases (Fig. 4a,
Supplementary Fig. 8a, Supplementary Video 8). During non-
contractile phases, the trailing edge remained motionless and
appeared to be passively dragged by the protruding cell front
(Supplementary Video 7). These observations suggest that in
contrast to slow moving cells, protrusion and contraction are
spatio-temporally dissociated in leukocytes.
Receptor-mediated force transduction can only support forward
movement if retrograde (contractile) but not anterograde (protrus-
ive) forces are coupled to the environment2,3. To address how
actomyosin contraction functionally contributes to leukocyte loco-
motion, we pharmacologically inhibited myosin II or its upstream-
activator, Rho kinase. Irrespective of the presence of integrin
function, either treatment severely reduced migration speeds of
DCs, granulocytes and B cells (Fig. 4b, Supplementary Fig. 8e, data
not shown). Nevertheless, the chemotactic gradient was still able to
polarize the cell population. The leading edges of cells remained
dynamic and protruded with normal speed towards the chemokine

































































































Figure 3 | Integrin-independent leukocyte migration in 3D networks
in vitro. a, 2D adhesion versus 3D migration of DCs. b, 2D adhesion on
ICAM-1 and fibronectin (FN) 1 h after LPS stimulation. Top, quantification
of the number of adherent cells (ICAM-1, n5 6; FN, n5 8 for each
experiment). Bars, median values with interquartile range, *P, 0.05 (post
hoc). Bottom, morphology of wild-type (WT), integrin2/2 (Itg2/2) and
talin12/2 (Tln12/2) DCs. c, d, Velocities of chemotaxing leukocytes in 3D
collagenmatrices. c, Top, DCs (4 experiments per group); d, granulocytes, B
cells. Dots, single cells; red line, mean. c, Bottom, single cell tracks of
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Figure 4 | Myosin II-dependent nuclear squeezing at the cell rear.
a, Sequence of a myosin light chain (MLC)–GFP expressing wild-type (WT)
dendritic cell (DC) migrating towards CCL19 in a 3D collagen gel; upper
row, differential interference contrast (DIC) microscopy; lower row,
MLC–GFP intensity profiles (encoded in pseudo-colours with red
representing highest levels). Time in min:s. b, Left, velocities of single DCs
(dots; red line, median), and right, DC morphology (coloured red, DIC
microscopy), chemotaxing towards CCL19 in 3D collagen gels upon
pharmacological inhibition. c, Speed of cell bodies (rear) versus cell
protrusions (front) of DCs in the presence of inhibitor; red line, median.
Bleb, blebbistatin; *P, 0.05 (post hoc). d, e, Time-lapse sequence of a WT
(d) and integrin2/2 (e) DC either with (lower row) or without (upper row)
blebbistatin; DICmicroscopy, nuclei (green). Time inmin:s; scale bars, 5 mm
(a), 10 mm (b, d, e).
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(Fig. 4b–e, Supplementary Fig. 8b–d, Supplementary Video 9). This
functional dissociation between front and back caused up to 30-fold
cell elongation, and demonstrates that the leading edge migrates
autonomously and without a need for receptor-mediated coupling
of contractile forces to the extracellular matrix.
Trailing edge contraction propels the nucleus
How does trailing edge contraction contribute to cell body loco-
motion? In fibroblasts and leukocytes moving on 2D substrates,
actomyosin contraction at the back is required to disassemble recep-
tor binding-sites and subsequently retract the membrane2,21,22.
Hence, blocking contraction causes membrane tethers at the trailing
edge. Consistent with an adhesion-independent migration mode, we
could not observe membrane tethers in myosin II-inhibited leuko-
cytes migrating in 3D gels. We considered that the elongated pheno-
type with its rounded back was caused by the inability to move an
internal resistance through narrow gaps within the gel. As the nucleus
is the least elastic cellular compartment23, we visualized DNA within
chemotaxing DCs and granulocytes. In untreated cells, we observed
continuous shape changes of nuclei, indicating deformation forces,
while upon myosin II inhibition, spherical nuclei were immobilized
at the rear ends of the cells (Figs 4d, e, Supplementary Fig. 8b–d,
Supplementary Videos 10, 11).
Protrusion drives basal locomotion
Although ‘locked’ nuclei caused migration arrest in most cells, a few
still showed locomotion. This residual migration was often charac-
terized by cell body elongation and dragging of the nucleus (Fig. 5a,
Supplementary Video 12). Such non-contractile movement was in
line with our previous observations showing motile phases in the
absence of trailing edge contractions. We hypothesized that such
myosin II-independent migration might occur in areas of the col-
lagen gel where external resistance was low due to increased spacing
of the collagen fibres. To establish the relationship between internal
contractile force and external resistance, we analysed DC chemotaxis
in collagen gels of varying fibre spacing (Fig. 5b). In all collagen
densities, myosin II-inhibited DCs were slower than untreated cells
but importantly, they ‘caught up’ at lowest gel densities (Fig. 5b,
Supplementary Video 13). A comparison of instantaneous velocities
further showed that myosin II inhibition did not prevent DCs from
reaching the same peak values as untreated cells (Supplementary
Fig. 9a–c).
We conclude that, in contrast to the ‘blebbing’ model of amoeboid
cell migration24, cortical actin network contraction does not mediate
locomotion itself but rather facilitates a protrusive mode of migra-
tion in confined environments where protrusion alone is unable to
act against counter-forces. So in constricted areas, the cell overcomes
internal and external resistance (rigidity of the nucleus and fibre
density) by contraction (myosin II). Contractile force deforms the
resistance and facilitates a purely protrusive mode of migration.
To challenge the concept of protrusive movement, we treated che-
motaxing DCs with latrunculin B, which interferes with actin poly-
merization by depleting the pool of available functional G-actin
monomers25. We found that this treatment reduced cell migration
velocity in a dose-dependent manner (Fig. 5c). At intermediate con-
centrations, the trailing edge remained contractile and the nucleus
was ‘pushed’ to the cell front (Fig. 5d, Supplementary Video 14).
Consistent with a model where protrusion determines the speed of
cell migration while contraction is only activated to overcome
external resistances, the speed reduction of latrunculin B-treated cells
was independent of gel density (Fig. 5b, c).
Discussion
We show that leukocytes migrate in the absence of specific adhesive
interactions with the extracellular environment. This subversion of
the metazoan principle makes them autonomous from the tissue
context, and allows them to quickly and flexibly navigate through
any organ without adaptations to alternating extracellular ligands.
This strategy is in stark contrast to the haptokinetic migration prin-
ciple that leads along preformed pathways and therefore promotes
deterministic positioning. Adhesion independency better suits stoch-
astic movement or chemotaxis where cells randomly migrate or fol-
low soluble cues. Astonishingly, the protrusive flow of F-actin
appears sufficient to drive rapid leukocyte locomotion in environ-
ments with large pore-size. This resembles the locomotion principle
of nematode sperm cells that is entirely driven by treadmilling poly-
mers of major sperm protein26. Only in narrow areas do leukocytes
activate the contractile module to squeeze and propel the internal
resistance of the nucleus in a manner resembling neuronal
nucleokinesis27. This ‘flowing and squeezing’ migration model
fulfils a central requirement for immune cell movement: the pericel-
lular environment is transiently deformed but never digested28 or
CCL19
F2,147 = 18.9, P < 0.001
H2 = 53.6, P < 0.001





















































































Figure 5 | Myosin II-independent protrusive migration of dendritic cells.
a, Two types of residual migration of wild-type (WT) dendritic cells (DCs)
treated with blebbistatin in a standard 3D collagen gel. DCs either drag the
nucleus behind with elongated appearance and low speed (right column) or
appear morphologically normal with high speed (left column). Time in min.
b, Top panel, confocal reflection microscopy of 3D collagen networks of
different densities. Lower panels, velocities of single chemotaxing WT DCs
(dots) in collagen gels with varying densities. Upper graph, no inhibitor; red
line, mean. Middle graph, blebbistatin; red line, median. Bottom graph,
100nM latrunculin B (partial actin depolymerization); red line, median.
c, Velocity of singleWTDCs(dots) in thepresenceof different concentrations
of latrunculinB(1.6mgml21 collagen); red line,median. Inb andc,*P, 0.05
(post hoc).d, Time-lapse sequence of a 100nM latrunculinB-treatedWTDC;
DICmicroscopy,nuclei (green).Time,min:s. Blueboxes (inb andc) highlight
experimental conditions that were used for follow-up experiments indicated
by the blue arrow. Scale bars: 10mm (a, d), 50mm (b).
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otherwise permanently remodelled which avoids ‘collateral damage’,
caused by infiltrating cells.
The fact that leukocytes are able to move autonomously generates
a new level of regulatory possibilities. Because surface bound chemo-
kines and other immobilized extracellular signals do trigger integrin
affinity16 (unlike soluble chemokines), leukocyte integrins should no
longer be viewed as force transducers during locomotion but as
switchable immobilizing anchors that stop, slow down or confine
high intrinsic motility to specifically assigned surfaces29,30. The role
of integrins is therefore mostly to mediate retention, invasion, cell–
cell communication and cell–cell adhesion31.
METHODS SUMMARY
Generation of integrin-deficient leukocytes. Integrins and talin1 were targeted
by generatingmice with the genotype av
flox/flox (Supplementary Fig. 1), b1
flox/flox
(ref. 32), b2
2/2 (ref. 33), b7
2/2 (ref. 34), Mx1Cre1/2 (ref. 35) and talin1flox/flox
(ref. 36), Mx1Cre1/2, respectively. Cre expression in the haematopoietic system
was induced by intraperitoneal injection of 250mg Poly (I)?Poly (C) (Amersham
Biosciences). 10–14 d after knockout induction DCs were generated from bone
marrow suspension andmaturedwith lipopolysaccharide (LPS). TheDC culture
was depleted for granulocytes and remaining integrin-positive contaminants by
magnetic sorting (Miltenyi Biotech). DCs used for migration assays were.99%
enriched for b1 and av integrin knockout cells.
In situ live cell imaging. For dermal ex vivo microscopy, mouse ears were
mechanically separated in dorsal and ventral halves, fluorescently stained with
LYVE-1 antibody and immobilized with the epidermal side down. The dermis
was overlaid with fluorescently labelled DCs and time lapse movies were
recorded with an automated Leica MZ 16 FA stereomicroscope (Visitron
Systems).
In vitro 3D chemotaxis assays.Cells were suspended in PureCol (INAMED) and
cast in custom built migration chambers (standard collagen concentration:
1.6mgml21). After polymerization, gels were overlaid with culture medium
containing the chemoattractant (CCL19, C5a and CXCL13 for DCs, granulo-
cytes and B cells, respectively) and subsequently imaged using wide-field fluor-
escence video microscopes with differential interference contrast (Zeiss). For
nucleus visualization, SYTO-dyes (Invitrogen) were used. For visualization of
myosin light chain, DCs were nucleofected using Amaxa technology. Inhibitors
were titrated and used 50mm blebbistatin (Sigma) and 30 mm Y27632
(Calbiochem).
Statistical analysis. t-tests and analysis of variance (ANOVA) were performed
after data were confirmed to fulfil the criteria of normal distribution and equal
variance, otherwise Kruskal–Wallis tests or Mann–Whitney U-tests were
applied. If overall ANOVA or Kruskal–Wallis tests were significant, we per-
formed a post hoc test. Analyses were performed with Sigma Stat 2.03. For
further statistical details, see Supplementary Table.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Generation of integrinav
1/floxmice.To generate a conditional floxedav allele, a
targeting vector spanning 8.2 kb of the murine av integrin locus
37 was con-
structed. First, the 2.2 kb genomic subclone pXB2.2 encoding the 59 upstream
region, exon 1 and part of the intron 1 of the av gene was used to introduce two
loxP-sites. The 59-loxP1-site including an EcoRI-restriction site to facilitate
the identification of the targeted locus was cloned into the HindIII-site in the
59-upstream region (nucleotide position, nt-pos., –310) of the av gene. The
39-loxP2-site was introduced into the BamHI-site in intron 1 (nt-pos. 1528).
The genomic subclone pBS6 harbouring this BamHI-site at its 59-end and
,6 kb 39-downstream intron 1 sequences was used to clone a pgk-neo;pgk-tk-
tandem gene selection-cassette (neoTK) flanked by two frt-sites (provided by
G. R. Martin) into the BamHI-site. These two modified genomic regions of the
av gene were then fused at the corresponding BamHI-site to obtain the av gene
targeting vector. ES cell transfection, selection and screening was carried out as
described37 except that R1 ES cells38 were used. Homologously targeted clones
were identified by Southern blotting of EcoRI- or BamHI-digestedDNAwith 59-
or 39-external probes A or B, respectively. To excise the neoTK selection cassette,
targeted ES cells (flneoTK) were transiently transfected with the CAGGS-FLPe-
expression construct39 (provided by A. F. Stewart) and counterselected with
ganciclovir. Loss of the selection cassette in the av floxed allele was then con-
firmed by Southern blotting. ES cell clones were injected into blastocysts of
C57Bl/6 mice, and resulting germline transmitting male chimaeras were mated
to C57Bl/6 females to generate heterozygous floxed av mice and wild-type F1
mice following protocols as described37. Two independent lines carrying the
av
1/flox allele were established and initially maintained on a 129SV/C57BL/6
mixed background. av
1/flox and av
flox/flox mice show no obvious phenotype.
Southern blot and PCR analyses: wild-type and mutant av alleles were assessed
by Southern blot hybridization and/or PCR from DNA isolated from ES cells,
mouse tail biopsies or from yolk sacs of embryos as described37. In brief, 10 mg of
genomic DNA was digested with EcoRI or BamHI and analysed using radio-
labelled 59-external probe A (419 bp-EcoRI/XbaI DNA-fragment) or a 39-
external probe B (690 bp-SphI/EcoRI DNA-fragment), respectively (see
Supplementary Fig. 1). Genomic DNA digested with EcoRI was used to confirm
the presence or absence of the selection cassette with probe C encoding a 800 bp-
PstI fragment of the neomycin-resistance gene. For genotyping wild-type (WT,
1) and floxed av allele (flox) as well as the cre-mediated knockout allele (av
Dex1),
PCR amplifications with genomic DNA and the specific primer set (see below)
were performed. The positions of the primers are located in close vicinity to the
loxP-sites. PCR amplifications using Taq-polymerase and standard reaction
buffer adjusted to a final concentration of 1mM MgCl2 were carried out as
follows. PCR samples were initially denatured at 94 uC for 3min, followed by
35 cycles of amplification (94 uC for 1min, 60 uC for 2min, 72 uC for 3min), and
a final 10min extension at 72 uC followed. PCR amplification products were
separated through agarose gel electrophoresis. The allele-specific primer
sequences, pairs and orientation (forward, Fw; reverse, Rev), the primer pairs
and their corresponding PCR-product sizes are as follows: Primer-set (F30: 59-
AGGATGGAAGGGGAGGGAAATG-39 (Fw; WT), F20: 59-CTTGACCGCAA-
GCGCACAGCACAG-39 (Fw; WT), I2: 59-CTGGATGCTGAGTGTCAGGT-39
(Rev; WT)), PCR products (F20/I2: 499 bp (wild-type av allele, WT); F20/I2:
614 bp (floxed av allele, av
flox); F30/I2: 339 bp (cre-mediated av knockout allele,
av
Dex1)).
Mouse strains.Micewith constitutive deletions of integrinb7, integrinb2, CCR7
and conditional b1
flox/flox mice were described10,32–34. All mice were kept on a
mixed 129SV/C57BL/6 genetic background. The integrin targeted strains were





2/2, Mx1Cre1/2 animals. Talin1flox/flox mice36 were crossed with
Mx1Cre transgenic mice to obtain talin1flox/flox, Mx1Cre1/2 mice. All control
animals were on a mixed 129SV/C57BL/6 genetic background. The mice were
bred in a conventional animal facility at the Max Planck Institute of
Biochemistry, and according to the local regulations.
Induction of the haematopoietic knockout. At an age between 8 and 12weeks,
mice of the desired genotype received a single intraperitoneal injection of 250mg
Poly (I)?Poly (C) (AmershamBiosciences), diluted in 0.5ml phosphate buffered
saline (PBS). Mice were killed 10–14 d after injection and knockout efficiency of
haematopoietic precursors was estimated by flow cytometric analysis of
peripheral blood platelets40. Bone marrow (BM) of mice with .85% integrin
b1-negative platelets was processed for dendritic cell (DC) culture or cell isola-
tion. Platelet knockout efficiencies usually correspondedwith knockout efficien-
cies of DCs and granulocytes, whereas peripheral B cells frequently showed lower
efficiency.
Cell generation, separation and purification.DCs were generated from flushed
BM suspension as described previously41. At day 8–10 of culture, 200 ngml21
LPS (Sigma-Aldrich; E. coli 0127:B8) was added overnight and the pan-integrin-
deleted DCs were subsequently depleted of remaining Gr-11 and integrin b1
1
contaminants. For depletion, cells were incubated with biotinylated antibodies
against Gr-1 (RB6-8C5) and integrin b1 (Ha2/5) (both BD Pharmingen), fol-
lowed by streptavidin-microbead separation according to the manufacturers
protocol (Miltenyi Biotech). The negatively selected DCs used for migration
assays were.99% enriched for b1 integrin knockout cells and b1-deficient cells
were always 100% deleted for integrin av. After enrichment the cells are referred
to as integrin2/2DCs. Talin12/2DCswere generated identically and depleted of
Gr-11 contaminants. To determine knockout efficiencies, DC lysates were
loaded on 12–15% gradient gels for electrophoresis under reduced conditions
and western blotting. Talin was detected with mouse anti-pan-talin antibody
(T3287, Sigma), and the loading control was performed with rabbit anti-mouse
actin antibody (A2066, Sigma). Integrin b1 was detected with the rabbit poly-
clonal anti-integrin b1 antibody 1244
42. Integrin av was detected with a rabbit
polyclonal anti-integrin av antibody (Chemicon). Bound primary antibodies
were detected with anti-mouse or anti-rabbit horse radish peroxidase (HRP)
or anti-rabbit HRP (both Bio-Rad) as secondary antibodies, respectively. DCs
with no detectable talin stain were chosen for experiments, guaranteeing that the
cells were deleted for talin1 and that talin2was neither expressed nor induced as a
compensation mechanism in DCs. Granulocytes were isolated by staining whole
bone marrow suspension with anti-Gr-1 PE or anti-Gr-1 PE/anti-b1 FITC and
subsequent fluorescent activated cell sorting using a FACSAria (BDBiosciences),
revealing .96% purity. Before incorporation into the gels, granulocytes were
treated for 30minwith 20 ngml21 TNF-a (Roche) at 37 uC. B lymphoblasts were
generated by mincing spleens through a 70 mm nylon cell strainer (BD
Pharmingen), lysing erythrocytes with ACK lysis buffer (0.15M NH4Cl, 1mM
KHCO3, and 0.1mM EDTA), and subsequent magnetic cell sorting (MACS)
with mouse CD43MicroBeads on LS columns (Miltenyi). The negatively sorted
B cells were stimulated with 10 mgml21 LPS (Sigma) for 72 h at 37 uC, 5% CO2.
Streptavidin-microbead separation of integrin b1
1 cells (see DCs) revealed
.98% pan-integrin-deficient B lymphoblasts that we refer to as integrin2/2 B
lymphoblasts.
Flow cytometry. Mature DCs were identified as CD11c1, MHCIIhigh cells for
wild-type and talin1-deficient cells. For integrin2/2 cells, MHCIIhigh cells cor-
responded tomature DCs as they carried enhanced levels of maturationmarkers
CD86 and CD40. B lymphoblasts were identified as B2201 cells, granulocytes as
Gr-11 cells. Employed antibodies were against the mouse antigens: Gr-1 biotin
and PE (RB6-8C5), B220 FITC (RA3-6B2), CD11c FITC and biotin (HL3), I-A/
I-E biotin (2G9) and I-A/I-E PE (M5/114.15.2) (all from BD Pharmingen). For
integrin expression profiles, the above cell markers were combined with anti-
bodies raised against the mouse integrin chains: a2 FITC (Ha 1/29), aIIB FITC
(MWReg30), aMPE (M1/70), a4 PE (9C10), a5 PE (5H10-27), a6 PE (GoH3), aE
PE (M290), av (RMV-7), b1 biotin (Ha2/5), b2 biotin (C71/16), b3 biotin
(2C9.G2), b7 biotin (2C3.G2) (all from Pharmingen), a1 FITC (HMalpha1),
b4 PE (346-11A) (both from Serotec), aL biotin (M17/4) (eBiosciences) and
b1 PE (HMbeta1-1) (BioLegend). The following isotype-matched antibody con-
trols were employed: rat IgG2a PE (B39-4, R35-95), rat IgG1 PE (R3-34), ham-
ster IgG2 FITC (Ha4/8), hamster IgM FITC (G235-1) (all Pharmingen), rat
IgG2a biotin, rat IgG2b FITC (eB149/10H5), rat IgG1 FITC (all eBiosciences),
hamster IgG PE (HTK888), hamster IgM biotin (HTK204) (both BioLegend)
and rat IgG2a PE (YTH71.3) (Serotec). Biotinylated antibodies were detected
with secondary streptavidin-Cy5 (Jackson). Flow cytometric analysis was per-
formed with a FACScalibur and CellQuest Pro Software (BD Biosciences).
Quantitative RT–PCR.RNAwas isolated from sortedDCs (see above) using the
Absolutely RNAMicroprep Kit (Stratagene) and the RNeasy Mini Kit (Qiagen).
One microlitre cDNA, generated from 15 ng RNA using the iScript cDNA
Synthesis Kit (Bio-Rad), was subjected to real-time PCR with the iQ SYBR
Green Supermix (Bio-Rad) on the iCycler (Bio-Rad). Primers for integrin b1
59-AGACTTCCGCATTGGCTTTG-39 and 59-GCTGGTGCAGTTTTGTTCAC-
39, and integrin av 59-CAAGCTCACTCCCATCAC-39 and 59-GGGTGTCTT-
GATTCTCAAAGGG-39 were used. Integrin gene expression in wild-type and
integrin2/2 DCs was quantified with the Gene Expression Analysis Program for
the iCycler iQ Real-Time PCRDetection System (Bio-Rad). GAPDHwas used to
normalize gene expression, and integrin expression levels in wild-type DCs were
set to 1.
In vivo migration assay. Gr-1-depleted wild-type and integrin2/2 DCs were
labelled with 3.5mM cell-permeable 5-(and-6)-carboxyfluorescein succinimidyl
ester (CFSE) or 1mM tetramethylrhodamine (TAMRA) (both Invitrogen),
respectively, and vice versa (the fluorescent labels did not influence DC migra-
tion (not shown)). 13 106 DCs at a 1:1 ratio were suspended in 20 ml PBS and
injected subcutaneously into the hind footpads of C57BL/6 mice. 32 and 48 h
after injection, mice were killed by CO2 suffocation, popliteal lymph nodes
frozen in cryomatrix (Thermo) and sectioned in 12 mm slices. To visualize the
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lymph node compartments, methanol-fixed cryosections were stained after
blocking with 1% BSA in PBS with pan-laminin antibody (L9393, Sigma) and
secondary anti-rabbit Cy5 (Jackson). Three different layers of the T cell cortex of
each lymph node were documented using an Axio Imager upright microscope
(Zeiss). Quantification of DCs within the T cell cortex was performed with
MetaMorph (Molecular Devices). Using inverse thresholding, the greyscale
images of both fluorescence channels were separately binarized. DCs appeared
as dots that were quantified using the morphometric analysis tool. The ratio of
migrated knockout DCs was calculated as the number of knockout cells divided
by the total number ofDCs in the T cell cortex, with 0.5 as the value where 50%of
knockout cells and 50% wild-type cells located in the centre of the lymph node.
To confirm that fluorescent cells in the lymph node represent DCs that migrated
from the injection site (Supplementary Fig. 3), DCs were labelled with 3 mMCell
Trace Oregon Green 488 (Invitrogen). 13 106 DCs of either wild-type or integ-
rin2/2DCswere injected as described above and 48 h laterDCswere identified as
green cells expressing CD86 by flow cytometric analysis.
Ex vivo wide-field microscopy in ear dermis. Ears of killed C57BL/6 mice were
removed and mechanically split into dorsal and ventral halves. During separa-
tion the dermis detached from the cartilage layer that remained on one of the
halves. The cartilage free half was left unfixed and incubated with a rabbit poly-
clonal anti-LYVE-1 antibody (R&D Systems), washed with PBS and stained with
a A488 conjugated anti-rabbit secondary antibody (Molecular Probes). The
stained ears were mounted on custom-made migration chambers with the
dermal surface exposed. LPS-matured BM-derived, MACS-purified, TAMRA-
labelled DCs (see above) were re-suspended in culture medium, added on top of
the dermis and incubated for 30min at 37 uC, 5% CO2. After gently washing
away non-infiltrated DCs, the ear sheets were imaged in a custom-built climate
chamber using a fully motorized upright Leica MZ 16 FA stereomicroscope
equipped with a Spot camera and operated via MetaMorph software (system
implemented by Visitron Systems). For multiple immunofluorescence stainings
(Supplementary Fig. 5), ear sheets were fixed with 1% PFA after 120min immig-
ration of DCs and stained as described in the extravasation section. Cells were
manually tracked using ImageJ as described below.
Two-photon intravital microscopy in lymph nodes. Intravital microscopy was
performed as described previously43. Briefly, BM-derived DCs were matured
overnight with LPS, purified and selected by MACS for the desired integrin
deficiency (see above), differentially labelled with TAMRA and CFSE and sub-
cutaneously injected into footpads of C57BL/6 mice. After 32 h popliteal lymph
nodes were surgically exposed and imaged using an upright Leica DM LFSA
microscope equipped with a 320 0.95 NA water immersion objective
(Olympus) and a MaiTai Ti:sapphire-pulsed laser (Spectra-Physics). 3D cell
tracking was performed using Imaris software (Bitplane) as described.
In vivo ear irritation in bone marrow chimaeric mice. BM chimaera of





mals were generated by sublethal irradiation of wild-type mice and immediate
reconstitution with 13 106 suspended BM cells of the indicated genotype. Six
weeks after irradiation Poly (I)?Poly (C) was injected and 10 d later 20ml of 1%
croton oil (Sigma) in acetone44 was applied on mouse ears. Mice were killed 12 h
after applicationof crotonoil. For histological analysis dorsal and ventral halves of
earswere subjected towholemount immunostaining.After fixationwith 1%PFA,
ear halves were blocked with 1%BSA (PAA) in PBS for 1 h at RT (while shaking),
stained with anti-Gr-1 (RB6-8C5, Pharmingen) and anti-pan-laminin antibody
(L9393, Sigma) in 1% BSA in PBS overnight at 4 uC (while shaking) and washed
with 1% BSA in PBS. Primary antibodies were detected with a repeated cycle of
staining with anti-rabbit A488 (Molecular Probes) and anti-rat Cy3 (Dianova)
antibodies before tissuewas embedded in elvanol and representative images taken
with an Axio Imager (Zeiss) equipped with the Apotome. Concentration of gran-
ulocytes in blood was measured by staining peripheral blood with Gr-1 PE (BD
Pharmingen) and counting all granulocytes per blood sample by flow cytometry
using a FACSCalibur (BD Pharmingen). The numbers of granulocytes that extra-
vasated into ear dermis were quantified by morphometric analysis employing
MetaMorph imaging software (Molecular Devices).
3D collagen gel chemotaxis assay. For standard assays, PureCol (INAMED) in
13 minimum essential medium eagle (MEM, Sigma) and 0.4% sodium bicar-
bonate (Sigma) was mixed with cells in RPMI (Invitrogen), 10% fetal calf serum
(FCS, Invitrogen) at a 2:1 ratio, resulting in gels with a collagen concentration of
1.6mgml21. Final cell concentrations in the assay were 13 106 cells per ml gel
for DCs and 1.63 106 cells per ml gel for granulocytes and B lymphoblasts. For
collagen titration experiments, above ratios were adapted. For gels with
3–5mgml21 collagen concentration, Nutragen (INAMED) was employed.
Collagen-cell mixtures were cast in custom-made migration chambers with a
thickness of 0.5–1mm. After 30min assembly of the collagen fibres at 37 uC, the
gels were overlaid with 50 ml of the following recombinant chemokines (all R&D
Systems) diluted in RPMI, 10% FCS: CCL19 (0.6mgml21, DCs), C5a
(0.1mgml21, granulocytes) and CXCL13 (2.5mgml21, B cells). For inhibition
studies, leukocytes were pre-incubated for 30min with 50mM blebbistatin
(Sigma), 30 mM Y27632, 100 nM or 500 nM latrunculin B (both Calbiochem)
before casting the gels. Inhibitors were also present in the same end-
concentrations in the gel.
3D fibrin gel chemotaxis assay. Cells were taken up in 0.2% (w/v) human
fibrinogen (IMCO) in RPMI, 10% FCS to a final concentration of 13 106 cells
per ml gel. Before casting the gels in custom-made migration chambers,
0.125Uml21 thrombin (Calbiochem) was added. After 30min polymerization
of the fibrin gels at 37 uC, the gels were overlaid with 50 ml of 0.6mgml21 CCL19
(R&D Systems) in RPMI, 10% FCS.
Analysis of chemotaxis assays. For comparison of DC velocities in collagen and
fibrin gel assays in the absence of inhibitors (Fig. 3b and Supplementary Fig. 7a),
movies were converted to kymographs using MetaMorph imaging software.
Straight lines in the kymographs represent migrating cells and lead angles were
measured to calculate single cell velocities.Manual single cell tracking of random
samples employing ImageJ and the Manual Tracking Plugin revealed the same
results.Manual tracking was applied to all other 3D chemotaxis assays. Here cells
were tracked over 4 h (forDCs, 2min per frame) or 15min (for granulocytes, 15 s
per frame). Speed and directionality parameters were calculated and visualized as
plots and movies by analysing the acquired data with the Chemotaxis and
Migration Tool Plugin (http://www.ibidi.de/applications/ap_chemo.html).
For quantification of ‘‘resting’’ and ‘‘moving’’ phases in 0.75mgml21 collagen
gels (Supplementary Fig. 9) instantaneous velocities (distance per 2min) were
categorized as ‘‘resting’’ if velocity ,1mm per 2min and ‘‘moving’’ if velocity
$1mm per 2min. Average velocities during mobile phases were calculated by
excluding the resting fraction. The percentage of resting phases was calculated as
resting time / (resting time 1 moving time).
Time-lapse videomicroscopy. Lowmagnification bright-fieldmovies of DCs in
gels were recorded in indicated time intervals using inverted Axiovert 40 (Zeiss)
cell culture microscopes, equipped with custom-built climate chambers (5%
CO2, 37 uC, humidified) and PAL cameras (Prosilica) triggered by custom-made
software (SVS Vistek). High magnification DIC and fluorescence movies were
recorded using a fully automated Axiovert 200M inverted fluorescence micro-
scope with a 403 objective (Zeiss) and a CoolSNAP HQ CCD camera. The
microscopic set-up (Visitron Systems) was controlled by MetaMorph software.
Transfection and labelling of cells.DCswere transfectedwithMLC-GFP (gift of
M. Olson45) between days 8–10 of culture using the primarymouse T cell kit and
the Amaxa nucleoporator (Amaxa). Cells were transfected according to the
manufacturer’s recommendations and immediately after transfection LPS was
added for overnight maturation. For nucleus visualization of DCs and granulo-
cytes nucleic acid dyes SYTO11 and SYTO13 (Invitrogen) were used, respect-
ively, according to the manufacturers recommendations.
2D adhesion assays. Adhesion assays were performed in 24-well plates coated
with 10mgml21 fibronectin (Calbiochem) or 10mgml21 recombinant mouse
ICAM-1 (R&D). 33 105 DCs per well were seeded in RPMI medium containing
10%FCS in the presence of 200ngml21 LPS and incubated for 30min at 5%CO2,
37 uC. Same cell numbers of LPS-maturated DCs were seeded in the presence of
200ngml21 phorbol 12-myristate 13-acetate (Calbiochem) for 30min. Cellswere
washed manually 3 times with PBS, 1% BSA and subsequently photo-documen-
ted and counted manually. Time-lapse video microscopy of chemokine-induced
spreading of LPS-matured DCs (see Supplementary Video 4) was performed on
10mgml21 mouse CCL21 (R&D)-coated plastic of cell culture dishes.
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